Developments in Carbohydrate-Based Cancer Therapeutics.

Pharmaceuticals (Basel) · 2019 · PMC6631729 · PMID 31167407

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Results from the use of commercially available carbohydrate-based therapeutic agents has also not been shown to be highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.